Cancer Prevention Pharmaceuticals (Cancer Prevention Pharmaceuticals) Market Cap : $0.00 Mil (As of Apr. 29, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cancer Prevention Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cancer Prevention Pharmaceuticals's share price for the quarter that ended in Mar. 2016 was $0. Cancer Prevention Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Mar. 2016 was 7.43 Mil. Therefore, Cancer Prevention Pharmaceuticals's market cap for the quarter that ended in Mar. 2016 was $0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cancer Prevention Pharmaceuticals's Enterprise Value for Today is $0.00 Mil.

Cancer Prevention Pharmaceuticals Market Cap Historical Data

The historical data trend for Cancer Prevention Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cancer Prevention Pharmaceuticals Market Cap Chart

Cancer Prevention Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Market Cap

Cancer Prevention Pharmaceuticals Quarterly Data
	Dec13	Dec14	Mar15	Sep15	Dec15	Mar16
Market Cap	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Cancer Prevention Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Cancer Prevention Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cancer Prevention Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cancer Prevention Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Cancer Prevention Pharmaceuticals's Market Cap falls into.

Cancer Prevention Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cancer Prevention Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2015 is calculated as

Market Cap (A: Dec. 2015 )	=	Share Price (A: Dec. 2015 )	*	Shares Outstanding (EOP) (A: Dec. 2015 )
	=	$0	*	7.42991
	=	$0.00

Cancer Prevention Pharmaceuticals's Market Cap for the quarter that ended in Mar. 2016 is calculated as

Market Cap (Q: Mar. 2016 )	=	Share Price (Q: Mar. 2016 )	*	Shares Outstanding (EOP) (Q: Mar. 2016 )
	=	$0	*	7.42991
	=	$0.00

Cancer Prevention Pharmaceuticals (AMEX:CPP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Cancer Prevention Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Cancer Prevention Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Cancer Prevention Pharmaceuticals (Cancer Prevention Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cancer Prevention Pharmaceuticals Inc (AMEX:CPP) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.canprevent.com

Cancer Prevention Pharmaceuticals Inc is a pharmaceutical company. It was originally incorporated under the laws of the state of Arizona on June 9, 2008, as Cancer Prevention Pharmaceuticals, LLC and on December 22, 2009, Cancer Prevention Pharmaceuticals, Inc. was incorporated in the state of Delaware. The Company currently operates mainly in the development and commercialization of compound CPP-1X, otherwise known as DFMO or eflornithine. It is involved in familial adenomatous polyposis, neuroblastoma and the prevention of recurrence in colon cancer survivors. However, CPP also has therapeutic prevention approaches for prostate cancer, breast cancer, and skin cancers which will be developed together with the National Cancer Institute (as resources become available in the future) and multiple academic partners. Its competitors are Marina Biotech, Inc., SLA Pharma AG, StemSynergy Therapeutics, Inc. and Thetis Pharmaceuticals LLC. The Company holds license to approximately six issued patents in the United States. The Company's activities are subject to risks and uncertainties including failure to obtain required regulatory approvals to market the products, once developed, in the USA or foreign markets.